AAAAAA
Results:
1-19
|
Results: 19
Authors:
Laver, JH
Mahmoud, H
Pick, TE
Hutchinson, RE
Weinstein, HJ
Schwenn, M
Weitzman, S
Murphy, SB
Ochoa, S
Shuster, JJ
Citation: Jh. Laver et al., Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non Hodgkin's lymphoma: A Pediatric Oncology Group study, LEUK LYMPH, 42(3), 2001, pp. 399-405
Authors:
Lauer, SJ
Shuster, JJ
Mahoney, DH
Winick, N
Toledano, S
Munoz, L
Kiefer, G
Pullen, JD
Steuber, CP
Camitta, BM
Citation: Sj. Lauer et al., A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acutelymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trial, LEUKEMIA, 15(7), 2001, pp. 1038-1045
Authors:
Whitehead, VM
Payment, C
Cooley, L
Lauer, SJ
Mahoney, DH
Shuster, JJ
Vuchich, MJ
Bernstein, ML
Look, AT
Pullen, DJ
Camitta, B
Citation: Vm. Whitehead et al., The association of the TEL-AML1 chromosomal translocation with the accumulation of methotrexate polyglutamates in lymphoblasts and with ploidy in childhood B-progenitor cell acute lymphoblastic leukemia: a Pediatric OncologyGroup study, LEUKEMIA, 15(7), 2001, pp. 1081-1088
Authors:
Shuster, JJ
Citation: Jj. Shuster, Power and sample size for phase III clinical trials of survival, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 129-147
Authors:
Mulne, AF
Ducore, JM
Elterman, RD
Friedman, HS
Krischer, JP
Kun, LE
Shuster, JJ
Kadota, RP
Citation: Af. Mulne et al., Oral methotrexate for recurrent brain tumors in children: A Pediatric Oncology Group Study, J PED H ONC, 22(1), 2000, pp. 41-44
Authors:
Harris, MB
Shuster, JJ
Pullen, J
Borowitz, MJ
Carroll, AJ
Behm, FG
Camitta, B
Land, VJ
Citation: Mb. Harris et al., Treatment of children with early pre-B and pre-B acute lymphocytic leukemia with antimetabolite-based intensification regimens: a Pediatric Oncology Group Study, LEUKEMIA, 14(9), 2000, pp. 1570-1576
Authors:
Griffin, TC
Shuster, JJ
Buchanan, GR
Murphy, SB
Camitta, BM
Amylon, MD
Citation: Tc. Griffin et al., Slow disappearance of peripheral blood blasts is an adverse prognostic factor in childhood T cell acute lymphoblastic leukemia: a Pediatric Oncology Group study, LEUKEMIA, 14(5), 2000, pp. 792-795
Authors:
Woo, MH
Shuster, JJ
Chen, C
Bash, RO
Behm, FG
Camitta, B
Felix, CA
Kamen, BA
Pui, CH
Raimondi, SC
Winick, NJ
Amylon, MD
Relling, MV
Citation: Mh. Woo et al., Glutathione S-transferase genotypes in children who develop treatment-related acute myeloid malignancies, LEUKEMIA, 14(2), 2000, pp. 232-237
Authors:
Kaleem, Z
Shuster, JJ
Carroll, AJ
Borowitz, MJ
Pullen, DJ
Camitta, BM
Zutter, MM
Watson, MS
Citation: Z. Kaleem et al., Acute lymphoblastic leukemia with an unusual t(8;14)(q11.2;q32): a Pediatric Oncology Group study, LEUKEMIA, 14(2), 2000, pp. 238-240
Authors:
Maloney, KW
Shuster, JJ
Murphy, S
Pullen, J
Camitta, BA
Citation: Kw. Maloney et al., Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986-1994, LEUKEMIA, 14(12), 2000, pp. 2276-2285
Authors:
Mahoney, DH
Shuster, JJ
Nitschke, R
Lauer, S
Steuber, CP
Camitta, B
Citation: Dh. Mahoney et al., Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A pediatric oncology group study, J CL ONCOL, 18(6), 2000, pp. 1285-1294
Authors:
Pollock, BH
DeBaun, MR
Camitta, BM
Shuster, JJ
Ravindranath, Y
Pullen, DJ
Land, VJ
Mahoney, DH
Lauer, SJ
Murphy, SB
Citation: Bh. Pollock et al., Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: A pediatric oncology group study, J CL ONCOL, 18(4), 2000, pp. 813-823
Authors:
Schneider, NR
Carroll, AJ
Shuster, JJ
Pullen, DJ
Link, MP
Borowitz, MJ
Camitta, BM
Katz, JA
Amylon, MD
Citation: Nr. Schneider et al., New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group report of 343 cases, BLOOD, 96(7), 2000, pp. 2543-2549
Authors:
Pullen, J
Shuster, JJ
Link, M
Borowitz, M
Amylon, M
Carroll, AJ
Land, V
Look, AT
McIntyre, B
Camitta, B
Citation: J. Pullen et al., Significance of commonly used prognostic factors differs for children withT cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study, LEUKEMIA, 13(11), 1999, pp. 1696-1707
Authors:
Suryanarayan, K
Shuster, JJ
Donaldson, SS
Hutchison, RE
Murphy, SB
Link, MP
Citation: K. Suryanarayan et al., Treatment of localized primary non-Hodgkin's lymphoma of bone in children:A Pediatric Oncology Group study, J CL ONCOL, 17(2), 1999, pp. 456-459
Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation
Authors:
Rubnitz, JE
Camitta, BM
Mahmoud, H
Raimondi, SC
Carroll, AJ
Borowitz, MJ
Shuster, JJ
Link, MP
Pullen, DJ
Downing, JR
Behm, FG
Pui, CH
Citation: Je. Rubnitz et al., Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation, J CL ONCOL, 17(1), 1999, pp. 191-196
Authors:
Chang, MN
Shuster, JJ
Kepner, JL
Citation: Mn. Chang et al., Group sequential designs for Phase II trials with historical controls, CONTR CL TR, 20(4), 1999, pp. 353-364
Authors:
Contador, MP
Johnston, S
Smith, EI
Shuster, JJ
Hayes, FA
Castleberry, RP
Citation: Mp. Contador et al., Lymph node sampling in localized neuroblastoma: A Pediatric Oncology Groupstudy, J PED SURG, 34(6), 1999, pp. 967-974
Authors:
Whitehead, VM
Vuchich, MJ
Cooley, LD
Lauer, SJ
Mahoney, DH
Shuster, JJ
Payment, C
Koch, PA
Akabutu, JJ
Bowen, T
Kamen, BA
Ravindranath, Y
Emami, A
Look, AT
Beardsley, GP
Pullen, DJ
Camitta, B
Citation: Vm. Whitehead et al., Accumulation of methotrexate polyglutamates, ploidy and trisomies of both chromosomes 4 and 10 in lymphoblasts from children with B-progenitor cell acute lymphoblastic leukemia: a pediatric oncology group study, LEUK LYMPH, 31(5-6), 1998, pp. 507-519
Risultati:
1-19
|